Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b Trial of Selinexor Plus Doxorubicin in Advanced Soft Tissue Sarcomas (STS)

NCT03042819 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT03042819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03042819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b Trial of Selinexor Plus Doxorubicin in Advanced Soft Tissue Sarcomas (STS)
Lead sponsor
University Health Network, Toronto
Phase
Phase 1
Overall status
Completed
Start date
May 16, 2017
Completion date
June 30, 2021
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

soft tissue sarcoma